ReWalk Robotics (NASDAQ:RWLK – Get Rating) released its earnings results on Friday. The medical device company reported ($0.07) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.05) by ($0.02), Fidelity Earnings reports. ReWalk Robotics had a negative net margin of 213.48% and a negative return on equity of 16.05%. During the same period in the prior year, the business posted ($0.08) earnings per share.
RWLK opened at $0.95 on Friday. The business has a 50 day simple moving average of $1.09 and a two-hundred day simple moving average of $1.19. ReWalk Robotics has a one year low of $0.85 and a one year high of $2.78.
A number of research firms have commented on RWLK. Zacks Investment Research raised ReWalk Robotics from a “sell” rating to a “hold” rating in a research report on Thursday, April 28th. StockNews.com began coverage on ReWalk Robotics in a research report on Thursday, March 31st. They set a “sell” rating for the company.
Several hedge funds have recently bought and sold shares of RWLK. Goldman Sachs Group Inc. purchased a new position in shares of ReWalk Robotics during the 2nd quarter worth approximately $95,000. Jane Street Group LLC purchased a new position in shares of ReWalk Robotics during the 3rd quarter worth approximately $89,000. Credit Suisse AG purchased a new position in shares of ReWalk Robotics during the 4th quarter worth approximately $62,000. Millennium Management LLC purchased a new position in shares of ReWalk Robotics during the 4th quarter worth approximately $280,000. Finally, Virtu Financial LLC purchased a new position in shares of ReWalk Robotics during the 4th quarter worth approximately $64,000. Hedge funds and other institutional investors own 9.81% of the company’s stock.
ReWalk Robotics Company Profile (Get Rating)
ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes robotic exoskeletons for individuals with mobility impairments or other medical conditions in the United States, Europe, the Asia-Pacific, and Africa. The company offers ReWalk Personal and ReWalk Rehabilitation for spinal cord injuries and everyday use by paraplegic individuals at home and in communities; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke in the clinical rehabilitation environment; and MyoCycle and MediTouch tutor movement biofeedback devices for use at home or in clinic.
- Get a free copy of the StockNews.com research report on ReWalk Robotics (RWLK)
- The Three Most Upgraded Stocks You Can Buy Now
- MarketBeat: Week in Review 5/9 – 5/13
- Is Electronic Arts (NASDAQ: EA) Suddenly A Safe Haven?
- Beyond Meat Stock Value is Improving
- The Travel Sector Is Getting Upgraded
Receive News & Ratings for ReWalk Robotics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ReWalk Robotics and related companies with MarketBeat.com's FREE daily email newsletter.